GE10600002
Amersham™ Protran® Western blotting membranes, nitrocellulose
pore size 0.45 μm, roll W × L 300 mm × 4 m, pkg of 1 ea
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
shelf life
Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
packaging
pkg of 1 ea
manufacturer/tradename
Cytiva 10600002
roll W × L
300 mm × 4 m
pore size
0.45 μm pore size
Looking for similar products? Visit Product Comparison Guide
Related Categories
General description
Amersham Protran 0.45 NC is a nitrocellulose membrane with a 0.45 µm pore size for use in Western blot protocols. Amersham Protran nitrocellulose membranes offer excellent sensitivity, resolution, and low background noise, especially when used with Amersham ECL, Amersham ECL Prime, or Amersham ECL Select Western Blotting detection reagents. Protran NC membranes are available in popular precut sizes for a wide range of laboratory applications. This product was formerly called Protran BA85.
Application
Amersham™ Protran® Western blotting membranes, nitrocellulose is suitable for use in:
- Western blotting
- Southern blotting
- Northern blotting
Legal Information
Amersham is a trademark of Cytiva
Protran is a registered trademark of Cytiva
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
PLoS pathogens, 16(12), e1009166-e1009166 (2020-12-29)
Herpes simplex virus 1 (HSV-1) infects skin and mucosal epithelial cells and then travels along axons to establish latency in the neurones of sensory ganglia. Although viral gene expression is restricted during latency, the latency-associated transcript (LAT) locus encodes many
Cancer chemotherapy and pharmacology, 86(3), 361-374 (2020-08-11)
Glucocorticoids (GCs) are commonly used as therapeutic agents for immune-mediated diseases and leukemia. However, considerable inter-individual differences in efficacy have been reported. Several reports indicate that the inhibitor of mTOR rapamycin can reverse GC resistance, but the molecular mechanism involved
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service